GoingToMeet

The over-arching goals of the NDLR series of meetings are to bring together scientists and clinicians to discuss and debate current concepts in our understanding of the molecular basis of leukaemia, emerging paradigms, breakthroughs at the forefronts of leukaemia research and new therapies emerging in the clinic.

The NDLR series of meetings has established an international reputation for bringing together leaders in both basic and clinical leukaemia research covering the full spectrum of "bench to clinic" translational research

Confirmed international speakers include Prof. Michael Deininger, Oregon Health & Science University Cancer Institute, USA. Prof. Gary Gilliland, Brigham and Women's Hospital, Boston, USA. Prof. Tony Green, Cambridge Institute for Medical Research, UK. Prof. Nikolaus

Rajewsky, Max Delbrück Center for Molecular Medicine, Berlin, Germany. Prof. Daniel Tenen, Harvard Medical School, Boston, USA. Prof. Richard Van Etten, Tufts Medical Center, Boston, USA. Prof. Paolo Pandolfi, Harvard Medical School Boston, USA.